Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2010 Mar;66(Pt 3):233-42.
doi: 10.1107/S0907444909054298. Epub 2010 Feb 12.

Structure of the unbound form of HIV-1 subtype A protease: comparison with unbound forms of proteases from other HIV subtypes

Affiliations
Comparative Study

Structure of the unbound form of HIV-1 subtype A protease: comparison with unbound forms of proteases from other HIV subtypes

Arthur H Robbins et al. Acta Crystallogr D Biol Crystallogr. 2010 Mar.

Abstract

The crystal structure of the unbound form of HIV-1 subtype A protease (PR) has been determined to 1.7 A resolution and refined as a homodimer in the hexagonal space group P6(1) to an R(cryst) of 20.5%. The structure is similar in overall shape and fold to the previously determined subtype B, C and F PRs. The major differences lie in the conformation of the flap region. The flaps in the crystal structures of the unbound subtype B and C PRs, which were crystallized in tetragonal space groups, are either semi-open or wide open. In the present structure of subtype A PR the flaps are found in the closed position, a conformation that would be more anticipated in the structure of HIV protease complexed with an inhibitor. The amino-acid differences between the subtypes and their respective crystal space groups are discussed in terms of the differences in the flap conformations.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Ribbon diagram of the homodimer of the HIV-1 subtype A PR structure. Catalytic aspartic acids are shown as sticks. Blue spheres indicate amino acids that vary between subtype A PR and subtype B PR (numbers refer to amino-acid positions). Features of the PR structure are as labeled. This figure was generated using PyMOL (DeLano, 2002 ▶).
Figure 2
Figure 2
Stereo 2|F o| − |F c| OMIT map centered on the active site of HIV-1 subtype A PR. The map is contoured at 1.3σ and includes a 4 Å radius buffer around flap residues and water positions. All atoms of the flap (residues 46–55 and 46′–55′), the active-site aspartates Asp25 and Asp25′ and two waters (depicted as red spheres) were omitted from the calculation of the map.
Figure 3
Figure 3
Stereo superposition of unbound PR homodimers. (a) Complete PR homodimers, (b) close-up of the flap regions shown in (a) viewed down the twofold axis. Color code: green, dimers in tetragonal space groups with semi-open flaps; red, dimers in tetragonal space groups with wide-open flaps; blue, dimers in the hexagonal space group P61 with closed flaps. Note that the tips of the flaps invert between the semi-open and closed conformations. PDB coordinates were as used in Fig. 5 ▶. This figure was generated using PyMOL (DeLano, 2002 ▶).
Figure 4
Figure 4
Sequences of HIV-1 PR structures.
Figure 5
Figure 5
Pairwise r.m.s.d.s of Cα—Cα distances (Å).
Figure 6
Figure 6
Stereo figure showing the crystal contacts of HIV-1 subtypes. (a) Wide open (PDB code 2pc0; Heaslet et al., 2007 ▶), (b) semi-open (PDB code 2hb2; Heaslet et al., 2007 ▶) and (c) closed (PDB code 3ixo). PDB coordinates were as used in Fig. 7 ▶. Colored spheres represent the amino acids involved in contacts. A contact is calculated from the sum of atomic radii. This figure was generated using PyMOL (DeLano, 2002 ▶).
Figure 7
Figure 7
Packing contacts (colored cells represent crystal-packing contacts).

Similar articles

Cited by

References

    1. Abecasis, A. B., Deforche, K., Bacheler, L. T., McKenna, P., Carvalho, A. P., Gomes, P., Vandamme, A. M. & Camacho, R. (2006). J. Antivir. Ther.11, 581–589. - PubMed
    1. Baldanti, F., Paolucci, S., Ravasi, G., Maccabruni, A., Moriggia, A., Barbarini, G. & Maserati, R. (2008). J. Med. Virol.80, 947–952. - PubMed
    1. Berman, H. M., Westbrook, J., Feng, Z., Gilliland, G., Bhat, T. N., Weissig, H., Shindyalov, I. N. & Bourne, P. E. (2000). Nucleic Acids Res.28, 235–242. - PMC - PubMed
    1. Brodine, S. K., Mascola, J. R., Weiss, P. J., Ito, S. I., Porter, K. R., Artenstein, A. W., Garland, F. C., McCutchan, F. E. & Burke, D. S. (1995). Lancet, 346, 1198–1199. - PubMed
    1. Brünger, A. T., Adams, P. D., Clore, G. M., DeLano, W. L., Gros, P., Grosse-Kunstleve, R. W., Jiang, J.-S., Kuszewski, J., Nilges, M., Pannu, N. S., Read, R. J., Rice, L. M., Simonson, T. & Warren, G. L. (1998). Acta Cryst. D54, 905–921. - PubMed

Publication types